Evaluation of Botulinum TOXin Type A in the Treatment of Buerger’s Disease
Condition(s):Buerger Disease; Raynaud SyndromeLast Updated:July 12, 2023Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Buerger Disease; Raynaud SyndromeLast Updated:July 12, 2023Not yet recruiting
Condition(s):Raynaud PhenomenonLast Updated:March 5, 2024Recruiting
Condition(s):Raynaud PhenomenonLast Updated:July 10, 2019Recruiting
Condition(s):Raynaud PhenomenonLast Updated:December 6, 2023Recruiting
Condition(s):Systemic Sclerosis; Raynaud Phenomenon; Digital Ulcer; SclerodermaLast Updated:March 23, 2022Recruiting
Condition(s):Scleroderma (Limited and Diffuse); Undifferentiated Connective Tissue Disease; Raynaud Disease; Vascular Disease; Healthy Control SubjectsLast Updated:August 14, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.